AIG
CNCE

American International Group’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

American International Group’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-17,229
Closed -$86 – 3337
2021
Q1 		$86 Buy
17,229
+45
+0.3% +$364 ﹤0.01% 2784
2020
Q4 		$217 Buy
17,184
+81
+0.5% +$923 ﹤0.01% 2247
2020
Q3 		$168K Sell
17,103
-389
-2% -$3.83K ﹤0.01% 2235
2020
Q2 		$174K Buy
17,492
+1,642
+10% +$15.7K ﹤0.01% 2203
2020
Q1 		$140K Buy
15,850
+2,360
+17% +$23.3K ﹤0.01% 2114
2019
Q4 		$124K Sell
13,490
-113
-0.8% -$801 ﹤0.01% 2500
2019
Q3 		$80K Sell
13,603
-94
-0.7% -$997 ﹤0.01% 2724
2019
Q2 		$164K Buy
13,697
+120
+0.9% +$1.29K ﹤0.01% 2364
2019
Q1 		$164K Sell
13,577
-441
-3% -$6.5K ﹤0.01% 2320
2018
Q4 		$176K Sell
14,018
-109
-0.8% -$1.5K ﹤0.01% 2255
2018
Q3 		$210K Buy
14,127
+257
+2% +$4.04K ﹤0.01% 2398
2018
Q2 		$233K Buy
13,870
+2,415
+21% +$46.9K ﹤0.01% 2267
2018
Q1 		$262K Sell
11,455
-616
-5% -$13.7K ﹤0.01% 2121
2017
Q4 		$312K Buy
12,071
+57
+0.5% +$1.15K ﹤0.01% 2062
2017
Q3 		$177K Buy
12,014
+898
+8% +$13K ﹤0.01% 2355
2017
Q2 		$155K Buy
11,116
+960
+9% +$14.1K ﹤0.01% 2434
2017
Q1 		$173K Buy
10,156
+677
+7% +$8.12K ﹤0.01% 2271
2016
Q4 		$98K Sell
9,479
-25
-0.3% -$228 ﹤0.01% 2620
2016
Q3 		$96.1K Buy
9,504
+14
+0.1% +$153 ﹤0.01% 2620
2016
Q2 		$107K Buy
9,490
+483
+5% +$6.15K ﹤0.01% 2562
2016
Q1 		$123K Hold
9,007
– – ﹤0.01% 3253
2015
Q4 		$171K Sell
9,007
-16
-0.2% -$348 ﹤0.01% 3003
2015
Q3 		$169K Buy
9,023
+10
+0.1% +$170 ﹤0.01% 2986
2015
Q2 		$134K Buy
+9,013
New +$137K ﹤0.01% 3411

Other funds holding CNCE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

American International Group's CNCE Position: Q2 2021 in Review

American International Group sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q2 2021, closing a stake of 17,229 shares — an estimated $86 sold.

American International Group first reported a position in CNCE in Q2 2015 and held it in 24 quarters. The position peaked at $312K in Q4 2017. 79 funds tracked by Wall St. Rank hold CNCE as of Q2 2021.

  • American International Group reported no remaining Concert Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • American International Group sold 17,229 Concert Pharmaceuticals, Inc. shares in Q2 2021, an estimated $86.
  • American International Group first reported a position in Concert Pharmaceuticals, Inc. in Q2 2015 and held it in 24 quarters.
  • American International Group's Concert Pharmaceuticals, Inc. position peaked at $312K in Q4 2017.
  • 79 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q2 2021.

Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.